Intraoperative visualisation and treatment of salivary glands in Sjögren’s syndrome by contrast-enhanced ultrasound sialendoscopy (CEUSS): protocol for a phase I single-centre, single-arm, exploratory study

Introduction We established a promising sialendoscopic treatment for in vivo enhancement of salivation in salivary glands affected by Sjögren’s syndrome (SS). In this technique, the ducts of the salivary glands are irrigated with saline and steroids. This allows for dilatation of ductal strictures a...

Full description

Saved in:
Bibliographic Details
Main Authors: Arjan Vissink, K Hakki Karagozoglu, Tim Forouzanfar, Henk S Brand, Derk Hendrik Jan Jager, Marco Helder, Joseph Bot, Otto Kamp, Seunghee Cha, Gary Weisman, Imke Bartelink
Format: Article
Language:English
Published: BMJ Publishing Group 2020-09-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/9/e033542.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841554652669149184
author Arjan Vissink
K Hakki Karagozoglu
Tim Forouzanfar
Henk S Brand
Derk Hendrik Jan Jager
Marco Helder
Joseph Bot
Otto Kamp
Seunghee Cha
Gary Weisman
Imke Bartelink
author_facet Arjan Vissink
K Hakki Karagozoglu
Tim Forouzanfar
Henk S Brand
Derk Hendrik Jan Jager
Marco Helder
Joseph Bot
Otto Kamp
Seunghee Cha
Gary Weisman
Imke Bartelink
author_sort Arjan Vissink
collection DOAJ
description Introduction We established a promising sialendoscopic treatment for in vivo enhancement of salivation in salivary glands affected by Sjögren’s syndrome (SS). In this technique, the ducts of the salivary glands are irrigated with saline and steroids. This allows for dilatation of ductal strictures and removal of debris. Unfortunately, it is not possible to assess the delivery and penetration of saline or medications in the ductal system and parenchyma. To address this problem, we will conduct contrast-enhanced ultrasound sialendoscopy (CEUSS) using sulphur hexafluoride microbubbles. To the best of our knowledge, microbubbles have never been used for the treatment of salivary glands in SS. It is, therefore, imperative to test this application for its safety and feasibility.Methods and analysis A single-arm phase I study will be performed in 10 SS patients. Under local anaesthesia, ultrasound (US) guided infusion of the parotid and submandibular glands with microbubbles will be performed. Continuous US imaging will be used to visualise the glands, including the location of strictures and occlusions. Main outcomes will be the evaluation of safety and technical feasibility of the experimental treatment. Secondary outcomes will consist of determinations of unstimulated whole mouth saliva flow, stimulated whole mouth saliva flow, stimulated parotid saliva flow, clinical oral dryness, reported pain, xerostomia, disease activity, salivary cytokine profiles and clinical SS symptoms. Finally, salivary gland topographical alterations will be evaluated by US.Ethics and dissemination Ethical approval for this study was obtained from the Medical Ethics Committee of the Amsterdam University Medical Centre, Amsterdam, The Netherlands (NL68283.029.19). data will be presented at national and international conferences and published in a peer-reviewed journal. The study will be implemented and reported in line with the Standard Protocol Items: Recommendations for Interventional Trials’ statement.Trial registration numbers The Netherlands Trial Register: NL7731, MREC Trial Register: NL68283.029.19; Pre-results.
format Article
id doaj-art-aa58c41dc5ac4da099a88078e97d021d
institution Kabale University
issn 2044-6055
language English
publishDate 2020-09-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-aa58c41dc5ac4da099a88078e97d021d2025-01-08T12:20:08ZengBMJ Publishing GroupBMJ Open2044-60552020-09-0110910.1136/bmjopen-2019-033542Intraoperative visualisation and treatment of salivary glands in Sjögren’s syndrome by contrast-enhanced ultrasound sialendoscopy (CEUSS): protocol for a phase I single-centre, single-arm, exploratory studyArjan Vissink0K Hakki Karagozoglu1Tim Forouzanfar2Henk S Brand3Derk Hendrik Jan Jager4Marco Helder5Joseph Bot6Otto Kamp7Seunghee Cha8Gary Weisman9Imke Bartelink102 Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsAmsterdam UMC and Academic Centre for Dentistry Amsterdam (ACTA), Oral and Maxillofacial Surgery/Oral Pathology, De Boelelaan 1117, Amsterdam, The NetherlandsDepartment of Oral and Maxillofacial Surgery / Oral Pathology, Amsterdam University Medical Center (Amsterdam UMC, Location VUmc) and Academic Centre for Dentistry Amsterdam (ACTA), Vrije Universiteit Amsterdam, Amsterdam, The NetherlandsDepartment of Oral Biochemistry, Academic Centre for Dentistry Amsterdam (ACTA), Amsterdam, The NetherlandsDepartment of Oral and Maxillofacial Surgery / Oral Pathology, Amsterdam University Medical Center (Amsterdam UMC, Location VUmc) and Academic Centre for Dentistry Amsterdam (ACTA), Vrije Universiteit Amsterdam, Amsterdam, The NetherlandsDepartment of Oral and Maxillofacial Surgery / Oral Pathology, Amsterdam University Medical Center (Amsterdam UMC, Location VUmc) and Academic Centre for Dentistry Amsterdam (ACTA), Vrije Universiteit Amsterdam, Amsterdam, The NetherlandsDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center (Amsterdam UMC, Location VUmc), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands3Amsterdam University Medical Center, location VUmc, Department of Cardiology, Amsterdam, NetherlandsOral Medicine, University of Florida, Gainesville, Florida, USADepartment of Biochemistry, MU Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USADepartment of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Center (Amsterdam UMC, Location VUmc), Amsterdam, The NetherlandsIntroduction We established a promising sialendoscopic treatment for in vivo enhancement of salivation in salivary glands affected by Sjögren’s syndrome (SS). In this technique, the ducts of the salivary glands are irrigated with saline and steroids. This allows for dilatation of ductal strictures and removal of debris. Unfortunately, it is not possible to assess the delivery and penetration of saline or medications in the ductal system and parenchyma. To address this problem, we will conduct contrast-enhanced ultrasound sialendoscopy (CEUSS) using sulphur hexafluoride microbubbles. To the best of our knowledge, microbubbles have never been used for the treatment of salivary glands in SS. It is, therefore, imperative to test this application for its safety and feasibility.Methods and analysis A single-arm phase I study will be performed in 10 SS patients. Under local anaesthesia, ultrasound (US) guided infusion of the parotid and submandibular glands with microbubbles will be performed. Continuous US imaging will be used to visualise the glands, including the location of strictures and occlusions. Main outcomes will be the evaluation of safety and technical feasibility of the experimental treatment. Secondary outcomes will consist of determinations of unstimulated whole mouth saliva flow, stimulated whole mouth saliva flow, stimulated parotid saliva flow, clinical oral dryness, reported pain, xerostomia, disease activity, salivary cytokine profiles and clinical SS symptoms. Finally, salivary gland topographical alterations will be evaluated by US.Ethics and dissemination Ethical approval for this study was obtained from the Medical Ethics Committee of the Amsterdam University Medical Centre, Amsterdam, The Netherlands (NL68283.029.19). data will be presented at national and international conferences and published in a peer-reviewed journal. The study will be implemented and reported in line with the Standard Protocol Items: Recommendations for Interventional Trials’ statement.Trial registration numbers The Netherlands Trial Register: NL7731, MREC Trial Register: NL68283.029.19; Pre-results.https://bmjopen.bmj.com/content/10/9/e033542.full
spellingShingle Arjan Vissink
K Hakki Karagozoglu
Tim Forouzanfar
Henk S Brand
Derk Hendrik Jan Jager
Marco Helder
Joseph Bot
Otto Kamp
Seunghee Cha
Gary Weisman
Imke Bartelink
Intraoperative visualisation and treatment of salivary glands in Sjögren’s syndrome by contrast-enhanced ultrasound sialendoscopy (CEUSS): protocol for a phase I single-centre, single-arm, exploratory study
BMJ Open
title Intraoperative visualisation and treatment of salivary glands in Sjögren’s syndrome by contrast-enhanced ultrasound sialendoscopy (CEUSS): protocol for a phase I single-centre, single-arm, exploratory study
title_full Intraoperative visualisation and treatment of salivary glands in Sjögren’s syndrome by contrast-enhanced ultrasound sialendoscopy (CEUSS): protocol for a phase I single-centre, single-arm, exploratory study
title_fullStr Intraoperative visualisation and treatment of salivary glands in Sjögren’s syndrome by contrast-enhanced ultrasound sialendoscopy (CEUSS): protocol for a phase I single-centre, single-arm, exploratory study
title_full_unstemmed Intraoperative visualisation and treatment of salivary glands in Sjögren’s syndrome by contrast-enhanced ultrasound sialendoscopy (CEUSS): protocol for a phase I single-centre, single-arm, exploratory study
title_short Intraoperative visualisation and treatment of salivary glands in Sjögren’s syndrome by contrast-enhanced ultrasound sialendoscopy (CEUSS): protocol for a phase I single-centre, single-arm, exploratory study
title_sort intraoperative visualisation and treatment of salivary glands in sjogren s syndrome by contrast enhanced ultrasound sialendoscopy ceuss protocol for a phase i single centre single arm exploratory study
url https://bmjopen.bmj.com/content/10/9/e033542.full
work_keys_str_mv AT arjanvissink intraoperativevisualisationandtreatmentofsalivaryglandsinsjogrenssyndromebycontrastenhancedultrasoundsialendoscopyceussprotocolforaphaseisinglecentresinglearmexploratorystudy
AT khakkikaragozoglu intraoperativevisualisationandtreatmentofsalivaryglandsinsjogrenssyndromebycontrastenhancedultrasoundsialendoscopyceussprotocolforaphaseisinglecentresinglearmexploratorystudy
AT timforouzanfar intraoperativevisualisationandtreatmentofsalivaryglandsinsjogrenssyndromebycontrastenhancedultrasoundsialendoscopyceussprotocolforaphaseisinglecentresinglearmexploratorystudy
AT henksbrand intraoperativevisualisationandtreatmentofsalivaryglandsinsjogrenssyndromebycontrastenhancedultrasoundsialendoscopyceussprotocolforaphaseisinglecentresinglearmexploratorystudy
AT derkhendrikjanjager intraoperativevisualisationandtreatmentofsalivaryglandsinsjogrenssyndromebycontrastenhancedultrasoundsialendoscopyceussprotocolforaphaseisinglecentresinglearmexploratorystudy
AT marcohelder intraoperativevisualisationandtreatmentofsalivaryglandsinsjogrenssyndromebycontrastenhancedultrasoundsialendoscopyceussprotocolforaphaseisinglecentresinglearmexploratorystudy
AT josephbot intraoperativevisualisationandtreatmentofsalivaryglandsinsjogrenssyndromebycontrastenhancedultrasoundsialendoscopyceussprotocolforaphaseisinglecentresinglearmexploratorystudy
AT ottokamp intraoperativevisualisationandtreatmentofsalivaryglandsinsjogrenssyndromebycontrastenhancedultrasoundsialendoscopyceussprotocolforaphaseisinglecentresinglearmexploratorystudy
AT seungheecha intraoperativevisualisationandtreatmentofsalivaryglandsinsjogrenssyndromebycontrastenhancedultrasoundsialendoscopyceussprotocolforaphaseisinglecentresinglearmexploratorystudy
AT garyweisman intraoperativevisualisationandtreatmentofsalivaryglandsinsjogrenssyndromebycontrastenhancedultrasoundsialendoscopyceussprotocolforaphaseisinglecentresinglearmexploratorystudy
AT imkebartelink intraoperativevisualisationandtreatmentofsalivaryglandsinsjogrenssyndromebycontrastenhancedultrasoundsialendoscopyceussprotocolforaphaseisinglecentresinglearmexploratorystudy